199 related articles for article (PubMed ID: 35967391)
1. MALT1 regulates Th2 and Th17 differentiation
Wang Q; Wang Y; Liu Q; Chu Y; Mi R; Jiang F; Zhao J; Hu K; Luo R; Feng Y; Lee H; Zhou D; Mi J; Deng R
Front Immunol; 2022; 13():913830. PubMed ID: 35967391
[TBL] [Abstract][Full Text] [Related]
2. Blood MALT1, Th1, and Th17 cells are dysregulated, inter-correlated, and correlated with disease activity in rheumatoid arthritis patients; meanwhile, MALT1 decline during therapy relates to treatment outcome.
Ye Z; Chen L; Fang Y; Zhao L
J Clin Lab Anal; 2022 Jan; 36(1):e24112. PubMed ID: 34788483
[TBL] [Abstract][Full Text] [Related]
3. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors.
Wang F; Liu G; Xiang L; Yuan J; Tao Y; Zhang L; Zhang A; Chang X
J Clin Lab Anal; 2022 Jun; 36(6):e24449. PubMed ID: 35500150
[TBL] [Abstract][Full Text] [Related]
4. MALT1 positively relates to Th17 cells, inflammation/activity degree, and its decrement along with treatment reflects TNF inhibitor response in ankylosing spondylitis patients.
Yuan J; Xiang L; Wang F; Zhang L; Liu G; Chang X; Zhang A; Tao Y
J Clin Lab Anal; 2022 Jul; 36(7):e24472. PubMed ID: 35622982
[TBL] [Abstract][Full Text] [Related]
5. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.
Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y
J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370
[TBL] [Abstract][Full Text] [Related]
6. Regulatory effect of nicotine on the differentiation of Th1, Th2 and Th17 lymphocyte subsets in patients with rheumatoid arthritis.
Wu S; Zhou Y; Liu S; Zhang H; Luo H; Zuo X; Li T
Eur J Pharmacol; 2018 Jul; 831():38-45. PubMed ID: 29715455
[TBL] [Abstract][Full Text] [Related]
7. MALT1 positively correlates with Th1 cells, Th17 cells, and their secreted cytokines and also relates to disease risk, severity, and prognosis of acute ischemic stroke.
Chen X; Zhang X; Lan L; Xu G; Li Y; Huang S
J Clin Lab Anal; 2021 Sep; 35(9):e23903. PubMed ID: 34273195
[TBL] [Abstract][Full Text] [Related]
8. PR-957 retards rheumatoid arthritis progression and inflammation by inhibiting LMP7-mediated CD4
Liu Q; Shen J; Wang J; Xia J; Yin J; Cheng G; Qian X; Jiang Y; Ge X; Wang Q
Int Immunopharmacol; 2023 Nov; 124(Pt A):110860. PubMed ID: 37716163
[TBL] [Abstract][Full Text] [Related]
9. Aberrant blood MALT1 and its relevance with multiple organic dysfunctions, T helper cells, inflammation, and mortality risk of sepsis patients.
Wang Y; Huang Q; He F
J Clin Lab Anal; 2022 Apr; 36(4):e24331. PubMed ID: 35262976
[TBL] [Abstract][Full Text] [Related]
10. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 exaggerates multiple organ injury, inflammation, and immune cell imbalance by activating the NF-κB pathway in sepsis.
Wang Y; Liu Z; Zhang M; Yu B; Ai F
Front Microbiol; 2023; 14():1117285. PubMed ID: 36960276
[TBL] [Abstract][Full Text] [Related]
11. Circulating PCSK9 relates to aggravated disease activity, Th17/Treg imbalance, and predicts treatment outcome of conventional synthetic DMARDs in rheumatoid arthritis patients.
Meng Y; Zheng X; Zhang Z; Geng H; Li X
Ir J Med Sci; 2023 Dec; 192(6):3187-3194. PubMed ID: 36826711
[TBL] [Abstract][Full Text] [Related]
12. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.
Ye L; Jiang B; Deng J; Du J; Xiong W; Guan Y; Wen Z; Huang K; Huang Z
J Immunol; 2015 Jun; 194(11):5110-9. PubMed ID: 25917106
[TBL] [Abstract][Full Text] [Related]
13. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
Guggino G; Giardina AR; Raimondo S; Giardina G; Sireci G; Dieli F; Peralta M; Alessandro R; Triolo G; Ciccia F
Clin Exp Rheumatol; 2014; 32(1):77-81. PubMed ID: 24429356
[TBL] [Abstract][Full Text] [Related]
14. The relationship of blood CDC42 level with Th1 cells, Th17 cells, inflammation markers, disease risk/activity, and treatment efficacy of rheumatoid arthritis.
Li Y; Yang W; Wang F
Ir J Med Sci; 2022 Oct; 191(5):2155-2161. PubMed ID: 34859333
[TBL] [Abstract][Full Text] [Related]
15. [Functional status of T helper cells in rheumatoid arthritis and effect of etanercept].
Lu TT; Zhu P; Li XY; Fan CM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):495-7. PubMed ID: 18466711
[TBL] [Abstract][Full Text] [Related]
16. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis.
Lina C; Conghua W; Nan L; Ping Z
J Clin Immunol; 2011 Aug; 31(4):596-605. PubMed ID: 21562776
[TBL] [Abstract][Full Text] [Related]
18. MALT1 in asthma children: A potential biomarker for monitoring exacerbation risk and Th1/Th2 imbalance-mediated inflammation.
Liu L; Gao Y; Si Y; Liu B; Liu X; Li G; Wang R
J Clin Lab Anal; 2022 May; 36(5):e24379. PubMed ID: 35353938
[TBL] [Abstract][Full Text] [Related]
19. Cell division control protein 42 correlates with lower disease risk and its elevation predicts better treatment response, and inhibits T-helper 17 cell differentiation in rheumatoid arthritis.
Yang Y; Huang L; Wu B
Inflammopharmacology; 2022 Dec; 30(6):2117-2125. PubMed ID: 35737168
[TBL] [Abstract][Full Text] [Related]
20. MALT1 Positively Relates to T Helper 1 and T Helper 17 cells, and Serves as a Potential Biomarker for Predicting 30-Day Mortality in Stanford Type A Aortic Dissection Patients.
Zong J; Yang L; Wei L; Wang D; Wang X; Zhang Z
Tohoku J Exp Med; 2023 Dec; 261(4):299-307. PubMed ID: 37704417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
